March 8, 2018
How not to do it? Mastering (or not) the hyperbole
In an age of incredible scientific advances and breakthroughs, it appears that the claims and hype may be progressing even more rapidly. Adam Feuerstein and Damian Garde at STAT very effectively highlight an example. Where are the days when the data spoke for themselves?
Biotech is full of chest-thumping press releases. This one thumps really hard
STAT | by ADAM FEUERSTEIN and DAMIAN GARDE | March 1, 2018
It takes a lot more than a ho-hum, $100 million check to stand out in a biotech startup world awash in easy money.
You need a hyperbolic, chest-thumping press release. A pile of adverbs and adjectives helps. Include a quote from a Very. Important. Venture Capitalist. And by all means, make promises about how your drug will change life as we know it, even though it’s never passed through an actual human being.
Or, just copy what Rubius Therapeutics did on Thursday. We annotated its latest check-cashing press release.